Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Made Scientific and Sentinel BioTherapeutics Announce a Strategic Manufacturing Partnership to Advance the Phase I/II Allogeneic ePP Encapsulated Cell Therapy Program

tumors, announced a strategic manufacturing partnership to support the Phase I/II clinical development of Sentinel's SENT-001. SENT-001 is an allogeneic, encapsulated cell therapy leveraging genetically engineered allogeneic ARPE-19 cells to enable...

Sun Pharma Announces the Launch of LEQSELVI™ (deuruxolitinib) in the United States for Treating Severe Alopecia Areata

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or affiliated companies, "Sun Pharma") announced LEQSELVI™ (deuruxolitinib) 8 mg tablets is now available...

TrueMed Partners with Alliance Pharmaceuticals Ltd to Combat Sophisticated Counterfeits Using AI-Powered Authentication

digital authentication technology to identify and act on threats instantly. "You can't fight 2025 counterfeits with 2010 tools," said Jyrki Berg, CEO of TrueMed. "Our collaboration with Alliance Pharmaceuticals Ltd shows what modern brand...

Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as the First Treatment for Dry Eye Disease Associated with MGD—A Breakthrough in Ophthalmology

Expert Consensus on MGD: Diagnosis and Treatment in 2023, there is no drug that directly targets the treatment of MGD 1. The incidence rate of DED in China is 21%-30% according to the Clinical Guidelines for Diagnosis and Treatment of Dry Eye 2....

Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418 Begins with First Patient Dosed

company developing next-generation oncology therapies, announced the first patient has been dosed in the Phase 1 portion of a Phase 1/2 clinical study evaluating AVZO-1418/DB-1418, a potential best-in-class, novel EGFR/HER3 bispecific antibody-drug...

With Fifth NovaSeq X Plus System in Europe, Novogene Europe Expands Sequencing Capabilities

to drive scientific breakthroughs." The NovaSeq X Plus – Illumina's most advanced sequencing platform – generates up to 16 terabases of data in 48 hours, enabling critical applications including whole-genome sequencing, single-cell RNA analysis,...

Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model: Tinnitus Research

The novel compound AC102 almost completely reversed tinnitus in a preclinical model after a single dose. At the same time, the damaged connections between the auditory nerve and inner ear sensory cells were restored. These findings were recently...

The European Commission grants Aurobindo Pharma approval to market the cancer drug, Dazublys

Aurobindo Pharma has received marketing authorisation for its cancer treatment medication Dazublys. In an exchange filing, the company said that CuraTeQ Biologics, a wholly owned subsidiary of the company dedicated to oncology and immunology...

Fresenius Expands Biosimilars Portfolio with Denosumab Launch in the U.S

(denosumab), respectively. Conexxence is available in a 60 mg/mL single-use prefilled syringe. Bomyntra is available in a 120 mg/1.7 mL vial and a 120 mg/1.7 mL single-use prefilled syringe. “Fresenius Kabi is very pleased to continue the...

Seraphina Therapeutics Announces C15:0 Reverses Key Aspects of Cellular Fragility Syndrome in a Second Model

A new independent study has revalidated the use of C15:0 to reverse core components of a newly discovered nutritional C15:0 deficiency syndrome, called Cellular Fragility Syndrome, which may be impacting as many as 1 in 3 people globally. C15:0...

Neurocrine Biosciences Presents New Post-Hoc Data from the KINECT®-HD Study, Demonstrating a Significant Reduction in Disease Burden with INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea

by those living with Huntington's disease, including memory loss, limitations with mobility and trouble swallowing." In the 12-week Phase 3 KINECT-HD clinical trial, INGREZZA demonstrated a significant reduction in chorea severity, as measured by...

Innovent Announces Approval from China's NMPA for Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist, for Chronic Weight Management

Medical Products Administration (NMPA) has approved mazdutide, a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in Chinese adults with overweight or obesity. Mazdutide is the...

To Redefine Specialty Care, Craft Telemedicine Launches with a Human-Centered Platform

Craft Telemedicine today announced the official launch of its innovative telemedicine platform that eliminates subscription models and empowers patients with unprecedented choice and transparency in their healthcare decisions. Unlike traditional...

Alafair Biosciences Announces Enrollment of First Patient in Multi-Center Study Testing VersaWrap® Tendon Protector for Achilles Repair

Alafair Biosciences, Inc., a leading innovator in medical device technology, is pleased to announce the first patient enrolled at UC Davis Foot and Ankle Orthopaedics Clinic, as part of a prospective, multi-center, controlled case series...

With New Offerings Like MIC+B12 Injections, Metformin Combinations, and More, Shed Expands Its Weight Management Support

support options for individuals at every stage of their health journey. The expanded product lineup includes MIC+B12 injections that support metabolic health and energy production, as well as two new oral combination therapies: Metformin +...

enGene’s Detalimogene Receives RMAT Designation from the FDA, Opening the Path for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer

multi-cohort, Phase 2 LEGEND trial to establish its safety and efficacy in high-risk NMIBC. LEGEND’s pivotal cohort (Cohort 1) consists of approximately 100 patients with high-risk, BCG-unresponsive NMIBC with CIS (with or without papillary...

Kashiv BioSciences Announces Positive Topline Results from the Confirmatory Efficacy Study of ADL-018, a Biosimilar Candidate to XOLAIR® (omalizumab).

LLC announced positive topline results from its confirmatory clinical efficacy and safety clinical trial evaluating ADL-018, a proposed biosimilar to XOLAIR® (omalizumab). The randomized, double-blind, multicenter study assessed the efficacy and...

Fierce CRO Award Winner Crown Bioscience Named for Excellence in Global Operations.

trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer...

Setting a New Standard for End-to-End Traceability and Data Integrity, Waters Enhances Alliance iS HPLC System Software.

for customers. Globally, more than 80% of novel drugs have been submitted to regulatory authorities using Empower Software.1 With this release, the Alliance iS HPLC System delivers leading touchscreen security by offering individual and...

Enhancing Preclinical Research Support, SoBran, Inc. Expands BioScience Services to Los Angeles

full confidence that their animal care and facility operations meet the highest standards. About SoBran, Inc. Founded in 1987, SoBran, Inc. provides professional services in bioscience, engineering, logistics, and security. The company is dedicated...